ID29082A - Komposisi liposom imunogenik - Google Patents

Komposisi liposom imunogenik

Info

Publication number
ID29082A
ID29082A IDW20010900A ID20010900A ID29082A ID 29082 A ID29082 A ID 29082A ID W20010900 A IDW20010900 A ID W20010900A ID 20010900 A ID20010900 A ID 20010900A ID 29082 A ID29082 A ID 29082A
Authority
ID
Indonesia
Prior art keywords
imunogenic
liposomic composition
liposomic
composition
imunogenic liposomic
Prior art date
Application number
IDW20010900A
Other languages
English (en)
Indonesian (id)
Inventor
Gary Fujii
Donald V Cramer
William A Ernst
Jill Adler-More
L Jeanne Perry
Original Assignee
Molecular Express Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Express Inc filed Critical Molecular Express Inc
Publication of ID29082A publication Critical patent/ID29082A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IDW20010900A 1998-09-22 1999-09-02 Komposisi liposom imunogenik ID29082A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10135198P 1998-09-22 1998-09-22
US40072399A 1999-09-21 1999-09-21

Publications (1)

Publication Number Publication Date
ID29082A true ID29082A (id) 2001-07-26

Family

ID=26798150

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010900A ID29082A (id) 1998-09-22 1999-09-02 Komposisi liposom imunogenik

Country Status (31)

Country Link
EP (1) EP1115382B1 (ja)
JP (1) JP2002526436A (ja)
KR (1) KR100592825B1 (ja)
CN (1) CN1555254A (ja)
AP (1) AP2010A (ja)
AT (1) ATE468108T1 (ja)
AU (1) AU766772B2 (ja)
BG (1) BG65675B1 (ja)
BR (1) BR9914004A (ja)
CA (1) CA2344173C (ja)
CY (1) CY1110718T1 (ja)
CZ (1) CZ20011013A3 (ja)
DE (1) DE69942393D1 (ja)
DK (1) DK1115382T3 (ja)
EA (1) EA004797B1 (ja)
EE (1) EE200100168A (ja)
ES (1) ES2345695T3 (ja)
GE (1) GEP20053444B (ja)
HK (1) HK1039064A1 (ja)
HU (1) HUP0105391A3 (ja)
ID (1) ID29082A (ja)
IL (2) IL141675A0 (ja)
MX (1) MXPA01002973A (ja)
NO (1) NO330685B1 (ja)
NZ (2) NZ528055A (ja)
OA (1) OA11657A (ja)
PL (1) PL206260B1 (ja)
SK (1) SK287670B6 (ja)
UA (1) UA75327C2 (ja)
WO (1) WO2000016746A2 (ja)
ZA (1) ZA200101829B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200726479A (en) 2005-04-12 2007-07-16 Univ Duke Method of inducing neutralizing antibodies to human immunodeficiency virus
CA2764424C (en) 2009-06-04 2019-12-31 National Institute Of Advanced Industrial Science And Technology Vaccine for mycoplasma infection
EA034702B1 (ru) 2011-04-26 2020-03-10 Молекулар Экспресс, Инк. Липосомные композиции
US10076567B2 (en) 2013-09-27 2018-09-18 Duke University MPER-liposome conjugates and uses thereof
AU2018250226A1 (en) * 2017-04-04 2019-10-10 Barinthus Biotherapeutics North America, Inc. Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
KR20240033309A (ko) * 2022-09-05 2024-03-12 주식회사 차백신연구소 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
SE462375B (sv) * 1985-10-15 1990-06-18 Morgaardshammar Ab Centro Traadblock
DE3776966D1 (de) 1986-05-20 1992-04-09 Wako Pure Chem Ind Ltd Funktionelle gruppen tragende liposome und verfahren zu deren herstellung.
FR2754543B1 (fr) 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires

Also Published As

Publication number Publication date
EA200100269A1 (ru) 2001-12-24
UA75327C2 (en) 2006-04-17
EP1115382A2 (en) 2001-07-18
PL206260B1 (pl) 2010-07-30
SK287670B6 (sk) 2011-05-06
HUP0105391A3 (en) 2006-02-28
CA2344173A1 (en) 2000-03-30
MXPA01002973A (es) 2003-03-27
IL141675A (en) 2007-06-17
NO20011406L (no) 2001-04-24
CZ20011013A3 (cs) 2002-03-13
HK1039064A1 (en) 2002-04-12
KR20010075261A (ko) 2001-08-09
IL141675A0 (en) 2002-03-10
BG65675B1 (bg) 2009-06-30
NZ510442A (en) 2003-10-31
DE69942393D1 (de) 2010-07-01
WO2000016746A2 (en) 2000-03-30
ZA200101829B (en) 2002-06-05
ES2345695T3 (es) 2010-09-29
WO2000016746A8 (en) 2000-08-10
WO2000016746A3 (en) 2000-11-23
EA004797B1 (ru) 2004-08-26
WO2000016746A9 (en) 2000-09-21
BR9914004A (pt) 2001-07-24
ATE468108T1 (de) 2010-06-15
AU766772B2 (en) 2003-10-23
NO330685B1 (no) 2011-06-06
JP2002526436A (ja) 2002-08-20
SK3222001A3 (en) 2001-09-11
PL348604A1 (en) 2002-06-03
BG105372A (en) 2001-10-31
AU6035199A (en) 2000-04-10
DK1115382T3 (da) 2010-09-06
CA2344173C (en) 2010-02-23
AP2010A (en) 2009-06-29
CN1555254A (zh) 2004-12-15
CY1110718T1 (el) 2015-06-10
HUP0105391A2 (hu) 2002-05-29
NO20011406D0 (no) 2001-03-20
AP2001002096A0 (en) 2001-03-31
GEP20053444B (en) 2005-02-25
OA11657A (en) 2004-12-08
EP1115382B1 (en) 2010-05-19
EE200100168A (et) 2002-06-17
NZ528055A (en) 2005-01-28
KR100592825B1 (ko) 2006-06-23

Similar Documents

Publication Publication Date Title
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
DE69921867D1 (de) Mikrobizide Zusammensetzung
ID29430A (id) Komposisi herbisida
IS5430A (is) Ný samsetning
ID26926A (id) Komposisi shampo pembentuk mode
ATE234552T1 (de) Landwirtschaftliche zusammensetzung
ID25508A (id) Komposisi dematologis
DE69942892D1 (de) Gaserzeugende zusammensetzung
DE69928862D1 (de) Zusammensetzung
DE69915204D1 (de) Stabilisierte Proteinzusammensetzung
ID21009A (id) Komposisi untuk supositori
ID23250A (id) Komposisi paroksetin
ID21906A (id) Komposisi adesif
DE69717927D1 (de) Insektizide Zusammensetzung
ID22405A (id) Komposisi pestisida
DE69824331D1 (de) Fungizide Zusammensetzung
ID29082A (id) Komposisi liposom imunogenik
ID26295A (id) Komposisi keras-ultraviolet
DK0862850T3 (da) Mejetærsker
ID26485A (id) Komposisi paroksetina
DE998539T1 (de) Kühlmittelzusammensetzung
ID28359A (id) Komposisi
DE69939964D1 (de) Gelförmige Zusammensetzung
DE69700503T2 (de) Fungizide Zusammensetzung